1. Home
  2. AMG vs CAI Comparison

AMG vs CAI Comparison

Compare AMG & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Affiliated Managers Group Inc.

AMG

Affiliated Managers Group Inc.

SELL

Current Price

$388.97

Market Cap

9.9B

Sector

Finance

ML Signal

SELL

Logo Caris Life Sciences Inc.

CAI

Caris Life Sciences Inc.

SELL

Current Price

$21.15

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMG
CAI
Founded
1993
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
9.7B
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
AMG
CAI
Price
$388.97
$21.15
Analyst Decision
Strong Buy
Buy
Analyst Count
7
14
Target Price
★ $466.71
$34.23
AVG Volume (30 Days)
304.6K
★ 3.8M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
★ 0.01%
N/A
EPS Growth
50.30
★ 69.79
EPS
★ 17.38
0.05
Revenue
★ $2,074,400,000.00
$812,033,000.00
Revenue This Year
$17.42
$28.81
Revenue Next Year
$9.39
$19.11
P/E Ratio
★ $22.70
$460.40
Revenue Growth
1.64
★ 96.97
52 Week Low
$246.11
$14.19
52 Week High
$408.07
$36.50

Technical Indicators

Market Signals
Indicator
AMG
CAI
Relative Strength Index (RSI) 52.16 27.92
Support Level $340.19 $16.52
Resistance Level $396.01 $23.66
Average True Range (ATR) 15.28 2.00
MACD 1.14 -1.21
Stochastic Oscillator 64.06 0.03

Price Performance

Historical Comparison
AMG
CAI

About AMG Affiliated Managers Group Inc.

Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of June 2026, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 16% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (31%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (53%)—had $942.4 billion in managed assets.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: